bit.bio announces cell therapy pipeline and expanded Scientific Advisory Board portfolioDynamk CapitalNovember 13, 2023
Virica Biotech Receives Grant through Ontario Genomics’ BioCreate accelerator portfolioDynamk CapitalNovember 8, 2023
Cytiva & RoosterBio Collaborate to Address Exosome Manufacturing Challenges portfolioDynamk CapitalOctober 25, 2023
Portfolio Company Vectron Biosolutions and Cytovance Biologics Partner to Improve Development of Biologics portfolioDynamk CapitalOctober 11, 2023
Portfolio company CellFE Biotech has closed their Series A funding round, securing $22 million in financing Dynamk CapitalSeptember 27, 2023
Curi Bio Launches Nautilus™ and Stingray™ Platforms for Advancing Translational Research portfolioDynamk CapitalSeptember 20, 2023
bit.bio and BlueRock Therapeutics announce collaboration to advance T cell (Treg) based therapies portfolioDynamk CapitalAugust 3, 2023
Alpenglow awarded $1.6M grant to develop AI-enabled smart microscopy and 3D cancer database Dynamk CapitalAugust 2, 2023
Alpenglow Biosciences CEO, Nick Reder Featured in Recent Pharma's Almanac Interview Dynamk CapitalJuly 17, 2023
Vernal Biosciences Announces an Additional $20MM in Funding to Expand GMP mRNA and LNP Manufacturing portfolioDynamk CapitalJune 29, 2023
Virica Biotch To Expand Domestic Vaccine Manufacturing Capacity with Government Support portfolioDynamk CapitalApril 24, 2023
Alpenglow Biosciences and Mayo Clinic enter collaboration agreement to advance pathology and drug development through 3D spatial biology portfolioDynamk CapitalApril 12, 2023
Portfolio Company Vectron Biosolutions Recently Published in Frontiers in Chemical Engineering portfolioDynamk CapitalMarch 20, 2023
RoosterBio & Repligen Collaborate to Advance Scalable Exosome Bioprocessing Dynamk CapitalMarch 15, 2023
Curi Bio Names Nicholas Geisse, Ph.D., as New Chief Executive Officer portfolioDynamk CapitalFebruary 16, 2023
Portfolio Company Envisagenics Featured in Recent Wuxi AppTec Interview Dynamk CapitalFebruary 10, 2023
Portfolio Company BitBio Recently Announced a Partnership with Automata portfolioDynamk CapitalFebruary 10, 2023
